Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6951 to 7000 of 8908 results

  1. Totally endoscopic robotically assisted coronary artery bypass grafting (IPG128)

    Interventional procedures, IPG128 - Issued: June 2005 --> We have moved interventional procedures guidance 128 to become HealthTech guidance 77. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  2. Interstitial laser therapy for fibroadenomas of the breast (IPG131)

    We have moved interventional procedures guidance 131 to become HealthTech guidance 80. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  3. Pancreatic islet cell transplantation (IPG13)

    NICE's guidance on pancreatic islet cell transplantation has now been replaced. Please see NICE's HealthTech guidance 165 for the full guidance on allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus and to NICE's HealthTech guidance 175 to view the full guidance on autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy issued to the NHS in England, Wales, Scotland and Northern Ireland.

    Withdrawn guidance

  4. Computed tomographic colonography (virtual colonoscopy) (IPG129)

    We have moved interventional procedures guidance 129 to become HealthTech guidance 78. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  5. Collagen injection for vocal cord augmentation (IPG130)

    We have moved interventional procedures guidance 130 to become HealthTech guidance 79. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  6. Low dose rate brachytherapy for localised prostate cancer (IPG132)

    We have moved interventional procedures guidance 132 to become HealthTech guidance 81. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  7. Insertion of extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women (IPG133)

    This guidance has been updated and replaced by NICE interventional procedures guidance 576.

    Withdrawn guidance

  8. Artificial intelligence (AI)-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment (HTE12)

    We have moved health technology evaluation 12 to become HealthTech guidance 696. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  9. Artificial intelligence (AI) technologies to aid contouring for radiotherapy treatment planning: early value assessment (HTE11)

    We have moved health technology evaluation 11 to become HealthTech guidance 695. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  10. Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment (HTE15)

    We have moved health technology evaluation 15 to become HealthTech guidance 701. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  11. Digital technologies for managing non-specific low back pain: early value assessment (HTE16)

    We have moved health technology evaluation 16 to become HealthTech guidance 712. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  12. Virtual ward platform technologies for acute respiratory infections: early value assessment (HTE13)

    We have moved health technology evaluation 13 to become HealthTech guidance 697. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  13. Digital technologies for delivering multidisciplinary weight-management services: early value assessment (HTE14)

    We have moved health technology evaluation 14 to become HealthTech guidance 700. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  14. Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment (HTE17)

    We have moved Health technology evaluation 17 to become HealthTech guidance 713. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  15. Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment (HTE18)

    We have moved Health technology evaluation 18 to become HealthTech guidance 718. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  16. Digital technologies to support self-management of COPD: early value assessment (HTE19)

    We have moved Health technology evaluation 19 to become HealthTech guidance 736. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  17. Cefiderocol for treating severe drug-resistant gram-negative bacterial infections (HTE2)

    We have moved HTE2 to become 'antimicrobial resistance guidance'. This is to better reflect what the purpose of this product is and to help you find relevant content more quickly. The guidance itself has not changed. See antimicrobial resistance guidance 2 on cefiderocol for treating severe drug-resistant gram-negative bacterial infections.

    Withdrawn guidance

  18. Artificial intelligence (AI) technologies to help detect fractures on X-rays in urgent care: early value assessment (HTE20)

    We have moved Health technology evaluation 20 to become HealthTech guidance 739. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  19. Robot-assisted surgery for soft tissue procedures: early value assessment (HTE21)

    We have moved Health technology evaluation 21 to become HealthTech guidance 742. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  20. Robot-assisted surgery for orthopaedic procedures: early value assessment (HTE22)

    We have moved Health technology evaluation 22 to become HealthTech guidance 743. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  21. Slide sheets for moving or repositioning a person: late-stage assessment (HTE23)

    We have moved Health technology evaluation 23 to become HealthTech guidance 745. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  22. Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessment (HTE24)

    We have moved Health technology evaluation 24 to become HealthTech guidance 746. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  23. Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment (HTE25)

    We have moved Health technology evaluation 25 to become HealthTech guidance 748. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  24. Drug-eluting stents for treating coronary artery disease: late-stage assessment (HTE26)

    We have moved Health technology evaluation 26 to become HealthTech guidance 747. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  25. Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessment (HTE28)

    We have moved health technology evaluation 28 to become HealthTech guidance 753. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  26. Topical antimicrobial dressings for locally infected leg ulcers: late-stage assessment (HTE27)

    We have moved health technology evaluation 27 to become HealthTech guidance 751. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  27. Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment (HTE3)

    We have moved Health technology evaluation 3 to become HealthTech guidance 660. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  28. One-piece closed bags for colostomies: late-stage assessment (HTE29)

    We have moved health technology evaluation 29 to become HealthTech guidance 754. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  29. Digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments: early value assessment (HTE30)

    We have moved health technology evaluation 30 to become HealthTech guidance 756. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  30. Compression products for treating venous leg ulcers: late-stage assessment (HTE32)

    We have moved Health technology evaluation 32 to become HealthTech guidance 758. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  31. Transcatheter heart valves for transcatheter aortic valve implantation to treat aortic stenosis: late-stage assessment (HTE31)

    We have moved Health technology evaluation 31 to become HealthTech guidance 757. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  32. Bed frames for adults in acute medical or surgical hospital wards: late-stage assessment (HTE33)

    We have moved Health technology evaluation 33 to become HealthTech guidance 759. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  33. CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessment (HTE4)

    We have moved Health technology evaluation 4 to become HealthTech guidance 663. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  34. ProKnow cloud-based system for radiotherapy data storage, communication and management: early value assessment (HTE5)

    We have moved Health technology evaluation 5 to become HealthTech guidance 664. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  35. Artificial intelligence (AI) technologies to aid opportunistic detection of vertebral fragility fractures: early value assessment (HTE34)

    We have moved Health technology evaluation 34 to become HealthTech guidance 760. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  36. Digital platforms to support cardiac rehabilitation: early value assessment (HTE35)

    We have moved Health technology evaluation 35 to become HealthTech guidance 761. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  37. Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment (HTE6)

    We have moved Health technology evaluation 6 to become HealthTech guidance 665. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  38. Point-of-care tests for urinary tract infections to improve antimicrobial prescribing: early value assessment (HTE7)

    We have moved Health technology evaluation 7 to become HealthTech guidance 674. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  39. Digitally enabled therapies for adults with anxiety disorders: early value assessment (HTE9)

    We have moved health technology evaluation 9 to become HealthTech guidance 676. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  40. Digitally enabled therapies for adults with depression: early value assessment (HTE8)

    We have moved health technology evaluation 8 to become HealthTech guidance 675. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  41. Prosthetic intervertebral disc replacement (IPG100)

    This guidance has been updated and replaced by NICE HealthTech guidance 197.

    Withdrawn guidance

  42. Uterine artery embolisation for fibroids (IPG1)

    This guidance has been updated and replaced by NICE HealthTech guidance 240.

    Withdrawn guidance

  43. Stent-graft placement in abdominal aortic aneurysm (IPG10)

    This guidance has been updated and replaced by NICE interventional procedure guidance 163.

    Withdrawn guidance

  44. Wireless capsule endoscopy for investigation of the small bowel (IPG101)

    We have moved interventional procedures guidance 101 to become HealthTech guidance 62. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  45. Gastroelectrical stimulation for gastroparesis (IPG103)

    Interventional procedures, IPG103 - Issued: December 2004 --> This guidance has been updated and replaced by NICE interventional procedure guidance 489.

    Withdrawn guidance

  46. Impedance-controlled endometrial ablation for menorrhagia (IPG104)

    Summary --> This guidance has been updated and replaced by NICE guideline CG44.

    Withdrawn guidance

  47. Coil embolisation of unruptured intracranial aneurysms (IPG105)

    We have moved interventional procedures guidance 105 to become HealthTech guidance 63. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  48. Laser in situ keratomileusis (LASIK) for the treatment of refractive errors (IPG102)

    This guidance has been replaced by NICE interventional procedure guidance 164.

    Withdrawn guidance

  49. Coil embolisation of ruptured intracranial aneurysms (IPG106)

    We have moved interventional procedures guidance 106 to become HealthTech guidance 64. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  50. Transobturator foramen procedures for stress urinary incontinence (IPG107)

    The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on transobturator foramen procedures for stress incontinence in January 2005. This guidance has been withdrawn as the use of this procedure is now covered in NICE guideline CG40. NICE has no plans to carry out further assessment of this procedure under the Interventional Procedures Programme.

    Withdrawn guidance